CMT and CSCO announce the 2013 Chinese Clinical Oncology Advances Awards

The 2013 Chinese Clinical Oncology Advancement Award was recently announced. A total of 14 research programs received the award organized by China Medical Tribune (CMT) and the Chinese Society of Clinical Oncology (CSCO). These projects covered a broad spectrum of clinical oncology specialty fields and were published in prestigious journals including Lancet Oncology and Journal of Clinical Oncology. USCACA clinical oncology research experts participated the award review and selection as special panel reviewers.

USCACA partner --CJC Wins the Title of 2013’ the Highest International Impact Academic Journal of China

"As the partner of the Chinese Journal of Cancer (CJC) for the past 3 years, USCACA is proud to announce that our society journal CJC wins the Title of 2013’s Highest International Impact Academic Journal of China. Below is a news release from Sun Yat-sen University where CJC is headquartered. Members of USCACA have organized a number of special issues on important topics including Cancer Drug Discovery, Systems Biology of Cancer, Cancer Autophagy, Mouse Model of Cancer, Signaling pathways of Cancer."
=======

Four outstanding young Chinese scientists received the 2013 Scholar Award from USCACA and NFCR

To facilitate and strengthen collaborations among cancer researchers and physicians in the United States and China, the US Chinese Anti-Cancer Association (USCACA) and the National Foundation for Cancer Research (NFCR) have established the Scholar Excellence Award for the USCACA-NFCR Scholar Exchange and Fellowship Program in Basic, Translational, and Clinical Studies.

USCACA partner -- The Chinese Journal of Cancer is supported by the International Impact-promoting Program for Chinese Sci-Tech Journals

Recently, the International Impact-promoting Program for Chinese Sci-Tech Journals has released the journal selection results. The Chinese Journal of Cancer (CJC), an English journal sponsored by Sun Yat-sen University Cancer Center, gained type B grant support from this program, with an annual national funding of 1,000,000 RMB for 3 consecutive years.

USCACA and NFCR are pleased to invite nominations for the USCACA-NFCR 2013 Scholar Awards

The USCACA and NFCR are pleased to invite nominations for the USCACA-NFCR 2013 Scholar Awards

The Awards will recognize four junior Chinese investigators on the basis of significant contributions in basic and translational cancer research

The Awards will be presented in a ceremony during the 3rd Guangzhou International Symposium on Oncology, November 7-9, 2013, Guangzhou, China.

Pages